Speakers
Cathy Critchlow
Vice President, Center for Observational Research
Amgen
Day One
TUESDAY, SEPTEMBER 29
5:15 pm | End of Summit & Virtual Happy Hour Begins
10:20 am | Chair’s Opening Remarks
Day Two
WEDNESDAY, SEPTEMBER 30
10:25 am | Chair’s Opening Remarks
5:00 pm | Chair’s Closing Remarks & End of Conference
11:15 am | Strategic Vision for RWE Generation Across the Product Lifecycle
Glynn Dennis
Senior Director of Data Science
AstraZeneca
Day Two
WEDNESDAY, SEPTEMBER 30
1:00 pm | Considerations for integrating digital and sensor data into the RWD ecosystem
Maarten Beekman
Respiratory Medical Director, International Region
AstraZeneca
Day One
TUESDAY, SEPTEMBER 29
4:15 pm | Case Study: RWE Global Opportunities & Emerging Markets
10:30 am | Panel: Determining Where Value Lies in RWE
David Anstatt
Executive Director, Center for Observational Research & Data Sciences
Bristol-Myers Squibb
Day One
TUESDAY, SEPTEMBER 29
2:45 pm | Understanding the Global RWE Regulatory Landscape
Day Two
WEDNESDAY, SEPTEMBER 30
10:30 am | Panel: Integration Within the Pharmaceutical Community
Dan Ollendorf
Director, Value Measurement & Global Health Initiatives
Center for the Evaluation of Value and Risk in Health (CEVR)
Day One
TUESDAY, SEPTEMBER 29
4:45 pm | Setting Standards for RWE in Comparative Effectiveness Research: Methods, Transparency & Governance
Angela Dobes
Vice President, IBD Plexus
Crohn’s & Colitis Foundation
Day One
TUESDAY, SEPTEMBER 29
2:15 pm | Identifying Gaps in Current Patient Care Partnering to Accelerate Patient-Centric Real-World Evidence
10:30 am | Panel: Determining Where Value Lies in RWE
Dan Hennessy
Vice President, Medical Affairs
EMD Serono
Day One
TUESDAY, SEPTEMBER 29
11:15 am | Interweaving RWE into the Strategic Fiber of Therapeutic Areas
10:30 am | Panel: Determining Where Value Lies in RWE
Francis Campion
Principal Lead
MITRE
Day Two
WEDNESDAY, SEPTEMBER 30
12:30 pm | Synthea: Augmenting RWD & Synthetic Data into a Limitless Platform
Jason Walonoski
Department Head
MITRE
Day Two
WEDNESDAY, SEPTEMBER 30
12:30 pm | Synthea: Augmenting RWD & Synthetic Data into a Limitless Platform
Patricia Schepman
Director, Global HEOR
Pfizer
Day One
TUESDAY, SEPTEMBER 29
3:45 pm | RWE Pre & Post Launch Elements
Sheena Thakkar
Manager, Global HEOR
Pfizer
Day One
TUESDAY, SEPTEMBER 29
3:45 pm | RWE Pre & Post Launch Elements
Frida Schain
CEO & Founder
Schain Research
Day One
TUESDAY, SEPTEMBER 29
10:30 am | Panel: Determining Where Value Lies in RWE
Day Two
WEDNESDAY, SEPTEMBER 30
3:00 pm | Strategizing Market Access - Ensuring Implementation for the Whole of the Drug Development Continuum
Amy Place
Senior Director, Field Medical Affairs
Scholar Rock
Day Two
WEDNESDAY, SEPTEMBER 30
4:00 pm | Global Medical Affairs (GMA): Lessons Learnt from Creating a Department
Javier Jimenez
Executive VP RWE & Late Phase
Syneos Health
Day One
TUESDAY, SEPTEMBER 29
12:15 pm | How to Use RWE to Better Define Trial Protocol: Syneos’s Case Studies
Michael Lees
Head of Value, Evidence and Portfolio Strategy
Takeda
Day Two
WEDNESDAY, SEPTEMBER 30
10:30 am | Panel: Integration Within the Pharmaceutical Community
Ipek Stillman
Head, Globak Health Economics
Takeda
Day Two
WEDNESDAY, SEPTEMBER 30
10:30 am | Panel: Integration Within the Pharmaceutical Community
Thomas Kristensen
Global Health Economics Lead Takeda
Takeda
Day One
TUESDAY, SEPTEMBER 29
12:45 pm | RWE and Patient Advocacy – Patient Centricity
Michael Lacey
Global Health Economics Lead
Takeda
Day One
TUESDAY, SEPTEMBER 29
12:45 pm | RWE and Patient Advocacy – Patient Centricity
Kevin Francis
Principal - Head of RWE, Insights & Analytics
Trinity
Day Two
WEDNESDAY, SEPTEMBER 30
2:30 pm | What is Normal? Using AI to Normalize & Control the Quality of Data Outputs
Omar Ali
Pharmacist Consultant
QIPP Adviser Payer Network
Day Two
WEDNESDAY, SEPTEMBER 30
4:30 pm | Understanding Market Access Methodology
